CompaniesPrism Pharmaceuticals

Prism Pharmaceuticals

defunct

About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (7)

View all

Total Trials

As Lead Sponsor

As Collaborator

Total Enrollment

531

By Phase

PHASE2: 3PHASE1: 3PHASE4: 1

By Status

COMPLETED: 4WITHDRAWN: 2TERMINATED: 1

Clinical Trials Pipeline7 trials

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

Today

NCT00181181

Hover over trial bars to see details

Recent Trials

NCT05829239Collaborator

ADI-PEG20, Obesity and Prediabetes

PHASE2Withdrawn

Started: Apr 1, 2024 · Completed: May 1, 2024

NCT00739193Lead Sponsor

A Randomized, Placebo-Controlled, Double-Blind, Double Dummy Trial To Determine The Relative Effect Of Pm101 Versus Placebo And Amiodarone IV On Blood Pressure In Subjects With Stable Congestive Heart Failure

PHASE2Withdrawn

Started: Aug 31, 2008 · Completed: Dec 31, 2008

NCT00700518Lead Sponsor

Dose Response to Topical Glyceryl Trinitrate in Patients With Raynaud's Phenomenon

PHASE1Completed

10 participants

Started: Jun 30, 2008 · Completed: Nov 30, 2008

NCT00641953Lead Sponsor

IMX-150 Cream for Diabetic Neuropathy

PHASE2Completed

155 participants

Started: Aug 31, 2007 · Completed: Mar 31, 2008

NCT00502346Lead Sponsor

A Trial to Determine the Relative Effect of PM101 I.V. Versus Placebo on Hemodynamics in Healthy Adult Volunteers

PHASE1Completed

342 participants

Started: Jul 3, 2007 · Completed: Nov 2, 2007

View all 7 trials →

Related Companies

Baxter 2011----------------------------------------if You Believe Any Of This Information Is Incorrect

acquired